公司资料
NEXGEL 股价、新闻与催化剂
- 股票代码:
- NXGL
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
0.38 USD (-33.54%)
收盘价
最后更新: 2026年8月17日
5.31M USD
市值
股价为何变动
Following the latest company update, “NEXGEL Reports Second Quarter 2026 Financial Results”, NXGL closed down 33.5% at $0.3755 on Aug 17, 2026. The move occurred in the trading session associated with this earnings update.
公司概览
业务概览
NexGel is a hydrogel and wound-care company focused on advanced dressings and delivery materials. Its business is centered on materials science rather than therapeutics or classic biotech.
所在地与行业分类
NexGel is headquartered in the United States and listed on NASDAQ. It sits in medical materials and wound care rather than biotechnology.
商业模式特征
The company depends on product adoption, distribution channels, and the ability to scale its hydrogel platform into healthcare and consumer applications. Investors focus on revenue growth, margin trends, and commercial execution.
生物医药行业定位
NexGel is outside biotech and belongs to the wound-care materials layer. Its stock is driven by product demand and execution, not clinical data.
未来催化剂
- NEXGEL’s catalysts are wound-care and medical-hydrogel product demand, along with any update that clarifies the commercial growth path. The market cares about recurring product usage.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。